Market Size (2014)
2014
$2.89B
Vertical: HealthcareBase Year: 201613 Sections
Market Size (2014)
2014
$2.89B
Projected (2023)
2023
$3.81B
CAGR (2014–2023)
3.1%
3.1%Key Players
101+
Suturing is a technique used to close cutaneous wounds. The prime goals of this technique includes closing dead spaces, reducing the risks of bleeding, strengthening wounds until healing, and making skin aesthetically pleasing. Various type of suture needles are available in the market such as, taper point needle, spatula needle, coronar tip needle, taper cutting, triangle needle, and others. Sometimes, the principle of choosing a suture needle also depends upon the type of tissue. For instance, taper point needles are usually preferred to suture tissues that are effortless to penetrate whereas tapercut or cutting needles are used for hard tissues.
Notably, rising number of surgical procedures and favourable reimbursement scenario for a number of surgical procedures are promoting the growth of suture needles market globally. Road accidents have found to be responsible for rising surgical procedures and occurrence of wounds due to injuries. For instance, according to a study published in the Journal of Injury and Violence Research in 2017, it is found that low and middle-income countries bear the major burden of road traffic incidents worldwide.
Despite these drivers, there are some issues associated with suture needles market. Increasing incidence of needle stick injuries and easy availability of alternatives may hinder the growth of market.
Geographically, Americas region is commanding the largest market share owing to the improvement in reimbursement policies and rising healthcare expenditure. According to the American Medical Association, Medicare has made various significant amendments in Ambulatory Surgery Center payment system (ASC).
The global suture needles market is expected to reach USD 3,809.4 million by 2023 from USD 3,076.5 million in 2016. This market is expected to grow at a stable CAGR of 3.1% during the forecast period 2017-2023.
On the basis of shape, the global suture needles market is classified into straight, j shape, compound curve, half curved, and others. In 2016, straight needles segment commanded the largest market share of 25.4% and half curved needle is expected to grow at a fastest CAGR of 3.5% during the forecast period 2017 to 2023.
On the basis of type, the global suture needles market is classified into eyed and eyeless. Eyeless segment commanded the largest market share of 55.7% in 2016, and this segment is also expected to grow at a fastest CAGR of 3.4% during the forecast period 2017 to 2023.
The Suture Needle Market market is projected to grow at a CAGR of 3.1% from 2014 to 2023.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Objective
To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of global suture needle market.
To provide comprehensive analysis of suture needle industry and its sub-segments in the global market, thereby providing a detailed structure of the industry. To provide detailed insights into the factors driving and restraining the growth of global suture needle market.To estimate the market size of global suture needle from 2014 to 2023. Wherein, 2014 & 2015 would be the historic period, 2016 shall be the base year, and 2017 – 2023 will be forecast period for the study.To analyze global suture needle market, on the basis of four main geographies namely, Americas, Europe, Asia-Pacific, and Middle East & Africa.To compare the products with respect to the various players in the marketTo provide country wise market value analysis for various segments of suture needle marketTo understand the demand-supply scenario and provide gap analysis of the industryTo analyze and provide upcoming technologies and trends in suture needle marketTo provide strategic profiling of key companies (manufacturers and distributors) present across the globe, and comprehensively analyze their competitiveness/competitive landscape in this market.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2016
Historical Period
2014 – 2016
Forecast Period
2016 – 2023
Primary Interviews
150+
Historical data (2014–2016) and forecast period (2016–2023)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansBargaining Power of Suppliers
The suppliers in the global suture needles industry are the developers and manufacturers of suture needles. Currently, a number of suppliers are present in the market due to the availability of huge opportunities for the development, huge demand, and increasing government support. Currently, the market consists of large number of players manufacturing suture needles, however, few existing key companies capture significant share in the global market and have the capability of fluctuating the costs of the devices. Switching cost of these suppliers is medium because suppliers tend to enter into long-term associations, partnership, and deals with the other device manufacturing companies. The overall bargaining power of suppliers in the global suture needles market is medium.
Bargaining Power of Buyers
The bargaining power of the buyers is medium to high in the global suture needles market due to the presence of huge number of device providers in the industry. Because of the difference in the services and products provided by the manufacturer, the buying power of the buyer increasing with increasing number of choices of the products. Thus, the number of manufacturers increases the selection arena of the sellers for the buyers, which leads to the high bargaining power. However, the buyers tend to use the products that have been provided by the top players irrespective of the pricing, which affects the power of a buyer in the industry.
Threat of New Entrants
The threat of new entrants is medium in the global suture needles market due to developing the potential market. Any manufacturing company is trying to enter the market is required to accept the mandatory regulatory standards issued by government authorities. Moreover, the technological advancements in the industry are more likely to attract new companies to enter the business. The rise in the demand for the curved suture needle into the market owing to its potential growth in the coming future is expected to attract the currently established and other manufacturers to focus more on this segment. There is a strong hold of the big companies in the global market, which can make the entry of the new players a bit difficult.
Threat of Substitutes
The threat of substitutes in the global suture needles market is pretty high. Buyer’s propensity to substitute is high due to great availability of substitutes in this market. However, quality and trust issue for the products provided by the new players, and excellent service provided by the existing players may restrict the threat by the substitutes to an extent. Also, the low-medium degree of switching cost may minimize the threat of substitutes.
Intensity of Rivalry
The degree of competition in the global suture needles market is considered to be high. Differentiation among existing players and introduction of the newer products is increasing the intensity of rivalry in the market. Suture needles manufacturing companies are trying to develop products with high quality, services, and enhanced safety to increase the demand for these products in developed countries and developing regions. To overcome the competition, players are engaged in partnering with the established organizations and welcoming tie-ups. Moreover, the players are also developing advanced products for differentiating their brand from competitors.
Market estimates by geography (2023)
InsightEurope leads with $1.11B by 2023, while North America is projected to grow fastest at a 3.7% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2014 | 2016 | 2023 | CAGR | SHARE |
|---|---|---|---|---|---|
| Asia Pacific | $599.10M | $708.40M | $810.10M | 3.4% | 21% |
| Europe | $833.50M | $975.90M | $1.11B | 3.2% | 29% |
| Middle East and Africa | $497.80M | $553.20M | $600.70M | 2.1% | 16% |
| South America | $200.50M | $217.80M | $231.20M | 1.6% | 6% |
| North America | $763.30M | $916.20M | $1.06B | 3.7% | 28% |
| Total | $2.89B | $3.37B | $3.81B | 3.1% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$3.81B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Straight | $988.20M | 3.1% | 89% |
| half curved | $918.90M | 3.1% | 89% |
| J Shape | $666.40M | 3.1% | 72% |
| Others | $636.00M | 3.1% | 53% |
| Compound curve | $599.90M | 3.1% | 89% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Suture Needle Market covering market dynamics, competitive landscape, and strategic outlook.
The Suture Needle Market market is projected to reach $3.81B by 2023, growing at 3.1% CAGR. The Straight segment holds the largest share.
Suture needles plays an important role in the placement of sutures in tissues. Sometimes, the principle of choosing a suture needle also depends upon the type of tissue. For instance, taper point needles are usually preferred to suture tissues that are effortless to penetrate whereas tapercut or cutting needles are used for hard tissues.
The suture needles market is expecting a stable growth during the forecasted period 2017-2023. The major driving factors for the market are increasing number of surgical procedures, and improvement in reimbursement policies. However, easy availability of alternatives, and rising number of needle stick injuries may hamper the market growth in coming future.
Facts & InformationWith the rising limiest of chronic diseases, need of surgical procedures has also been escalatingAs per the 2015 statistics suggested by Eurostat, cataract sugary, and colonoscopy were the two most common surgical procedures performed in European region. It is observed that in the year 2015, cataract sugary way performed one thousand times per 100,000 inhabitants specifically in Germany, Sweden, the Czech Republic, Luxembourg, Finland, Malta, Estonia, Austria, Portugal and France. Other common procedures include bronchoscopies, and transluminal coronary angioplastiesAccording to the Australian Institute of Health and Welfare, during 2015-16, there were 10.6 million hospitalization, and 1 in 4 hospitalization involved a surgical procedureAmerican Society of Plastic Surgeons stated that in the year 2016, around 1,780,987 cosmetic surgical procedures were performedRoad accidents hare also found to be responsible for rising surgical procedures, and occurrence of wounds due to injuries. For instance, according to a study published in the Journal of Injury and Violence Research it 2017, it is fond that low and middle income countries bear the major burden of road traffic incidents worldwideA study published in the International Journal of Contemporary Pediatrics, in 2016, stated that during 2014 to 2016, 195 children were admitted for road traffic accident in India and around 6.7% went through surgical procedure for complex injury
Interpretation
Suturing is an indispensable process during injury, incision or surgery as it helps in wound healing. For different wounds or surgical procedures distinct stitching styles have been used such as vertical mattress, layered closure, horizontal mattress, running suture, and many others. Demand for surgical procedures is on rise across the globe as surgery has become standard treatment for various health conditions
Impact
Suture needles market is expected to showcase tremendous growth on account of the rising number of surgical procedures as in most common surgeries suturing is an important aid for wound closure
Growth Enhancement Factor
This is an important aid in various surgical procedures such as endoscope assisted sugary, cosmetic plastic sugary, bariatric surgery, and others. The increasing number of surgical procedures is expected to escalated the demand for suture needles
Conclusion
The primary goals of suturing are reducing the risks of bleeding, closing dead space, strengthening wounds until healing, and to attain aesthetically pleasing and functional results. For all the facts and information, it is observed that rise in number of surgical procedures will also boost the suture needles market
Fact & Information
Suturing is the most common method used for the ulcer wound managementAccording to a 2016 study published in Wound Repair and Regeneration, it is found that occurrence of venous leg ulcers (VLU) is three to four times higher in population older than 80 years. Incidence of pressure ulcers (PU) five to seven times higher in people older than was as compared to 65 to 70 years old populationIt is also reported that care for chronic wound costs around USD 10 billion annually, and would care in persons aged 65 and older accounts for the majority of these costsAccording the report of WHO published in 2015, the geriatric population is excepted to double and reach 2.1 billion by 2050
Interpretation
Older adults are more vulnerable towards chronic wounds than younger people, and also wound healing slows with age. So, the rising geriatric population offers great opportunities to marketers to come up with the advancement in suture needles
Fact & Information
There is continuous surge for the adoption of technologically advanced suturing productsIn past few years various alternatives of suture needles have come forward such as staples, tapes, tissue adhesives, and othersBioWeld1 system by lonMed is a cold plasma system designed for surgical incision closureEthicon has also introduced various suturing products such as Dermabond Advanced Topical Skin Adhesive, and others
Interpretation
In past fay years various technologically advanced suturing products have been introduced in the market. These newly introduced products have tendency shift the market trend in their favor in near future
Impact
The alternatives introduced by existing, and new market players can strongly impact the growth of the market as these alternative products are continuously gaining popularity due to their better cosmetic results
Conclusion
From all the fats, and information, it is concluded that due to the benefits offered by the available alternatives such as less pain, better cosmetic outcome, and less time consumption, over conventional suturing may hamper the suture needle market
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 101 companies operating in the Suture Needle Market market, including revenue, employee count, and market positioning where available.
Showing 101 of 101 companies
Roboz Surgical Instrument
Company Headquarter: Gaithersburg, Maryland, United States Workforce: 11-50 employees Company Working: Roboz Surgical Instrument company is engaged in the wholesale distribution of surgical and other instruments, apparatus, and equipments.
Novavax, Inc.
Company Headquarters: Maryland, US Founded: 1987 Workforce: ~2,500 Company Working: Novavax, Inc. is a biotechnology company that commercializes and develops vaccines to prevent a wide range of infectious diseases. It designs recombinant nanoparticle vaccine technology that produces a strong immune response against a variety of pathogens. It is partnered with leading biopharma organizations, government agencies, research institutions, and foundations, namely the Coalition for Epidemic Preparedness Innovations (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), the Serum Institute of India Pvt. Ltd. (India), SK Bioscience (South Korea), CPL Biological (India), and Takeda Pharmaceuticals (US). It has seven research and manufacturing facilities. It has presence in regions namely North America, Europe, and the Middle East and Africa
Ology Bioservices, Inc
Company Headquarters: Florida, US Founded: 1999 Workforce: ~800 Company Working: Ology Bioservices, Inc. is an integrated biopharmaceutical company that develops and manufactures biopharmaceuticals and medical devices. It specializes in cell therapy, gene therapy, viral vectors, antibodies, oncolytic viruses, biopharmaceutical manufacturing, and vaccines. It has collaboration and partnerships with recognized government agencies, namely the Department of Defense and Medical Countermeasures Advanced Development and Manufacturing, which support it in developing biodefense products. Moreover, it has decades of experience in developing, licensing, and manufacturing proteins, therapeutics, and vaccines. It develops products to offer both commercial customers and US governments. Furthermore, it is a wholly owned company of National Resilience, Inc. (US), and assisting Resilience through its services includes regulatory support from preclinical through licensure and cGMP manufacturing up to biosafety level 3 (BSL3).
Cleveland Biolabs, Inc
Company Headquarters: New York, US Founded: 2003 Workforce: ~150 Company Working: Cleveland Biolabs, Inc. is an innovative biopharmaceutical company developing products to address immune system diseases and serious medical needs. It is specialized in offering products such as radiation injury products, immune-oncology, and orphan drugs. It has nine product candidates in its pipeline that have been developing directly through itself or its wholly owned companies, namely Incuron, LLC (US) and Panacela Labs, Inc. (US). It has a proprietary platform, namely the Advanced Immunomodulating Multi-Receptor System (AIMS) platform, which is designed to restore immune homeostasis. Moreover, it has collaboration with government agencies which supports the advanced development and procurement of new medical countermeasures including drugs, vaccines, diagnostics, and medical supplies in order to protect public health from chemical, biological, radiological, and nuclear threats.
Fabentech Biotech
Company Headquarters: Lyon, US Founded: 2009 Workforce: ~25 Company Working: Fabentech Biotech is a pharmaceutical company that develops and manufactures polyclonal antibody treatments. Its platform is safe, tested, and fully validated on polyclonal antibody technology for fighting high-priority biological agents that could threaten public health. It has many local, national, and international partners, namely the National Institutes of Health (UK), US Army, World Health Organization, and the European Defense Fund, who are supporting its biodefense product development. This is the only company in Europe that is able to produce biodefense solutions while adhering to the most strict international norms
Elusys Therapeutics, Inc
Company Headquarters: New Jersey, US Founded: 1998 Workforce: ~25 Company Working: Elusys Therapeutics, Inc. is a commercial-stage biopharmaceutical company that develops antibody-based products to treat infectious diseases. It has partnerships with renowned biodefense associations, including the Centers for Disease Control and Prevention (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), and the National Institute of Allergy and Infectious Diseases (US). It supplies its anthrax antitoxin products from the Strategic National Stockpile (US). Moreover, it is a wholly owned subsidiary of NightHawk Biosciences (US) and is expanding NightHawk's biodefense space while also complementing NightHawk’s RapidVax platform, which is designed to specifically target emerging biological threats
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Suture Needle Market